Diabetes Technol Ther 2024;26:673-685
Practical Strategies to Support GI Comfort While on GLP-1 Therapy Evidence-based approaches include slow dose escalation (allowing 4-week intervals between increases), eating smaller frequent meals, staying hydrated, and prioritizing soluble fiber
However, with the increased popularity of GLP-1RA, the so-called Ozempic Face has emerged
Debatri Datta August 14, 2024 Written By Dr
Summary: GLP-1 receptor agonists are not licensed for NAFLD treatment in the UK but may reduce liver fat and improve metabolic parameters when prescribed for type 2 diabetes or weight management in eligible patients with concurrent liver disease
Appetite suppressants Drugs like phentermine, diethylpropion, and benzphetamine may be covered by some plans as older medications